Related Experiment Video
Updated: Sep 13, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
NCCN Policy Summit: Advancing Diversity, Equity, and Inclusion in the Cancer Workforce
Ashley Orr1, Taneal Carter1, Alyssa A Schatz1
11National Comprehensive Cancer Network, Plymouth Meeting, PA.
Abstract:
Advancing diversity, equity, and inclusion (DEI) in the cancer workforce is critical to ensuring equitable health care outcomes for all populations. Challenges such as systemic bias, lack of mentorship opportunities, and insufficient funding for DEI initiatives hinder progress in creating a workforce that reflects the diverse patient population in the United States. Supporting DEI is a crucial strategy to enhance the effectiveness of cancer care and research. A cancer workforce that prioritizes DEI can enhance patient trust, improve health outcomes, and foster a culture of inclusivity. As the oncology landscape continues to evolve, political landscapes continue to shift, and patient populations become increasingly more diverse, stakeholders can navigate these complexities by working collaboratively to protect and advance initiatives to improve workforce representation, ultimately transforming the cancer care system into a more equitable and effective system for all. To advance the conversation on the importance of developing and implementing policy and practice strategies to support DEI in the cancer workforce, NCCN hosted the Policy Summit "Advancing Diversity, Equity, and Inclusion in the Cancer Workforce" on September 10, 2024, at the National Press Club in Washington, DC. Through keynote addresses and multistakeholder panel discussions, this hybrid event explored topics such as current cancer workforce challenges across both clinical and research professionals, the importance of representation in the health care workforce and its impact on care outcomes, and policy opportunities to improve recruitment and retention of diverse staff. Speakers and attendees featured multidisciplinary perspectives, including patients, providers, researchers, industry, caregivers, community-based organizations, patient advocates, and payers.
More Related Videos
09:55Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
10:03Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
Published on: July 5, 2019
Related Concept Videos
International Nursing Organizations I
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
Cancer Prevention
Some...
National Nursing Organizations II
The AACN emphasizes a healthy work environment through six standards to achieve an optimal patient outcome. The standards are appropriate staffing, meaningful recognition, collaboration, authentic leadership, effective communication, and decision-making. In addition, AACN provides certification programs, webinars, journals, and...
National Nursing Organizations I
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...